BRYN PHARMA, INC.

Profile

Company Names

BRYN PHARMA, INC.
BRYN PHARMA, LLC
EPI-NOW, LLC

Addresses

26 STILL HOLLOW RD, LEBANON, NJ 08833

7101 MILLSTONE RIDGE COURT, RALEIGH, NC 27614

518 NORTH HILLCREST ROAD, BEVERLY HILLS, CA 90210

Phone Numbers

412-401-1129
310-869-2204

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$127,403,450.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2025-04-10 
$4,692,830.00 
$4,692,830.00 
$0.00 
 
5
2023-04-25 
$26,724,100.00 
$30,000,000.00 
$3,275,900.00 
Equity 
4
2021-07-06 
$43,510,775.00 
$50,000,000.00 
$6,489,225.00 
Equity 
3
2019-10-18 
$26,000,000.00 
$35,000,000.00 
$9,000,000.00 
Equity 
2
2019-02-08 
$17,223,780.00 
$18,000,000.00 
$776,220.00 
Equity 
1
2018-07-16 
$9,251,965.00 
$15,000,000.00 
$5,748,035.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEPHEN 
 
BECKMAN 
EXECUTIVE OFFICER
BRYN PHARMA, LLC
JAMES 
 
BORNEMAN 
EXECUTIVE OFFICER
BRYN PHARMA, INC.
JIM 
 
BORNEMAN 
EXECUTIVE OFFICER
BRYN PHARMA, LLC
DAVID 
 
DWORACZYK 
EXECUTIVE OFFICER, DIRECTOR
EPI-NOW, LLC   |  BRYN PHARMA, LLC
KATE 
 
GRELL 
DIRECTOR
BRYN PHARMA, LLC
KATHERINE 
 
GRELL 
DIRECTOR
BRYN PHARMA, LLC
STEVEN 
 
HARTMAN 
EXECUTIVE OFFICER, DIRECTOR
EPI-NOW, LLC   |  BRYN PHARMA, LLC   |  SYNCHRONO GROUP, INC.   |  BRYN PHARMA, INC.
JEFF 
 
HARTNESS 
DIRECTOR
BRYN PHARMA, LLC   |  BRYN PHARMA, INC.
WILLIAM 
 
HUMPHRIES 
DIRECTOR
CLEARSIDE BIOMEDICAL, INC.   |  ACLARIS THERAPEUTICS, INC.   |  BRYN PHARMA, LLC
MICHAEL 
 
KASETA 
DIRECTOR
LIQUIDIA CORP   |  ALIMERA SCIENCES INC   |  BRYN PHARMA, LLC   |  BRYN PHARMA, INC.
STEVE 
 
KILLMEYER 
EXECUTIVE OFFICER
BRYN PHARMA, LLC
STEVEN 
 
KILLMEYER 
EXECUTIVE OFFICER
BRYN PHARMA, INC.
LISA 
 
LICHT 
DIRECTOR
MUNCHKIN, INC.   |  BRYN PHARMA, LLC   |  BRYN PHARMA, INC.
MICHELLE 
 
LOBEL 
EXECUTIVE OFFICER, DIRECTOR
EPI-NOW, LLC   |  BRYN PHARMA, LLC   |  BRYN PHARMA, INC.
SANDRA 
 
LOREAUX 
DIRECTOR
BRYN PHARMA, INC.
SANDY 
 
LOREAUX 
EXECUTIVE OFFICER, DIRECTOR
BRYN PHARMA, LLC
MARC 
 
RAPAPORT 
DIRECTOR
DOCTOR EVIDENCE LLC   |  THOROFARE ASSET BASED LENDING FUND IV, L.P.   |  THOROFARE ASSET BASED LENDING REIT FUND IV, LLC   |  BRYN PHARMA, LLC   |  NW ENTERTAINMENT, LLC   |  BRYN PHARMA, INC.   |  BALBOA GEOLOCATION, INC.
DALE 
 
SANDER 
EXECUTIVE OFFICER
BRYN PHARMA, LLC
RICK 
 
SCHADEN 
DIRECTOR
EPI-NOW, LLC
KATE 
 
SOPER DIAZ 
DIRECTOR
BRYN PHARMA, LLC   |  BRYN PHARMA, INC.
ANNE 
 
WHITAKER 
DIRECTOR
KNOW BIO, LLC   |  DANCE BIOPHARM HOLDINGS, INC.   |  CALADRIUS BIOSCIENCES, INC.   |  QURALIS CORP   |  BRYN PHARMA, LLC   |  BRYN PHARMA, INC.
ROBERT 
 
YANEZ 
EXECUTIVE OFFICER
BRYN PHARMA, LLC
JOSHUA 
 
ZIEL 
EXECUTIVE OFFICER
AERAMI THERAPEUTICS HOLDINGS, INC.   |  BRYN PHARMA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-08-14
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2025-04-10 
2023-07-05
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2023-04-25 
2023-05-10
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2023-04-25 
2022-10-11
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-06 
2021-12-17
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-06 
2021-07-20
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-06 
2020-06-22
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-18 
2019-11-04
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-18 
2019-02-21
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-08 
2018-07-30
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#